These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 4688187)

  • 1. The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):515-9. PubMed ID: 4688187
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.
    Mojica JJ; Schwenk ES; Lauritsen C; Nahas SJ
    Curr Pain Headache Rep; 2021 Dec; 25(12):77. PubMed ID: 34894295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can In Vitro-In Vivo Extrapolation Be Successful? Recognizing the Incorrect Clearance Assumptions.
    Benet LZ; Sodhi JK
    Clin Pharmacol Ther; 2022 May; 111(5):1022-1035. PubMed ID: 34731496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.
    Kwa A; Sprung J; Guilder MV; Jelliffe RW
    Ther Drug Monit; 2008 Jun; 30(3):379-89. PubMed ID: 18520611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin.
    Rubin P; Jackson G; Blaschke T
    Br J Clin Pharmacol; 1980 Jul; 10(1):33-9. PubMed ID: 7397054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal pump assistance--novel treatment for acute lidocaine poisoning.
    Freedman MD; Gal J; Freed CR
    Eur J Clin Pharmacol; 1982; 22(2):129-35. PubMed ID: 7094983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of narcotic agonist-antagonist drugs.
    Bullingham RE; McQuay HJ; Moore RA
    Clin Pharmacokinet; 1983; 8(4):332-43. PubMed ID: 6352139
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
    Miners JO; Wing LM; Lillywhite KJ; Smith KJ
    Br J Clin Pharmacol; 1984 Dec; 18(6):853-60. PubMed ID: 6152176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.
    Tucker GT; Bax ND; Lennard MS; Al-Asady S; Bharaj HS; Woods HF
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):21S-28S. PubMed ID: 6146336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pharmacological variability in estimated hepatic blood flow in man.
    Daneshmend TK; Jackson L; Roberts CJ
    Br J Clin Pharmacol; 1981 May; 11(5):491-6. PubMed ID: 6115663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein binding and disposition of lignocaine in the elderly.
    Cusack B; O'Malley K; Lavan J; Noel J; Kelly JG
    Eur J Clin Pharmacol; 1985; 29(3):323-9. PubMed ID: 4076329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of prazosin--1985.
    Vincent J; Meredith PA; Reid JL; Elliott HL; Rubin PC
    Clin Pharmacokinet; 1985; 10(2):144-54. PubMed ID: 3888489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increase in liver circulation with nifedipine].
    Nitsch J; Kuhnen R; Lüderitz B
    Klin Wochenschr; 1986 Oct; 64(21):1113-8. PubMed ID: 3807257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of increased hepatic uptake of unesterified fatty acid from serum of ethanol-treated rats.
    Abrams MA; Cooper C
    Biochem J; 1976 Apr; 156(1):47-54. PubMed ID: 942402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the cardiovascular effects of acupuncture (moxibustion) by propranolol in dogs during halothane anaesthesia.
    Lee DC; Lee MO; Clifford DH; Morris LE
    Can Anaesth Soc J; 1976 May; 23(3):307-18. PubMed ID: 938968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics in patients with cardiac failure.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1976; 1(6):389-405. PubMed ID: 799548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.